Once hyped, gene therapy still holds promise as an effective method for treating a variety of diseases. On the road to fulfilling that expectation, opportunities exist for young scientists who are excited by a still-emerging field, says Hannah Hoag.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A Broad Overview and Review of CRISPR-Cas Technology and Stem Cells
Current Stem Cell Reports Open Access 11 February 2016
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Author notes
Hannah Hoag is a science journalist based in Montreal.
- Hannah Hoag
Related links
Rights and permissions
About this article
Cite this article
Hoag, H. Gene therapy rising?. Nature 435, 530–531 (2005). https://doi.org/10.1038/nj7041-530a
Published:
Issue Date:
DOI: https://doi.org/10.1038/nj7041-530a
This article is cited by
-
A Broad Overview and Review of CRISPR-Cas Technology and Stem Cells
Current Stem Cell Reports (2016)
-
Tomorrow, Interrupted?: Risk, Ethics, and Medical Advance in Gene Transfer
Molecular Therapy (2009)